Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group

Abstract Given the heterogeneity of acute myeloid leukemia patients, it is necessary to identify patients considered fit for intensive therapy but who will perform poorly, and in whom alternative approaches deserve investigation. We analyzed 1034 fit adults ≤70 years intensively treated between 2012...

Full description

Saved in:
Bibliographic Details
Main Authors: Guadalupe Oñate, Ana Garrido, Montserrat Arnan, Helena Pomares, Ester Alonso, Mar Tormo, Marina Diaz-Beya, Susana Vives, Lurdes Zamora, Antonia Sampol, Rosa Coll, Olga Salamero, Marta Cervera, Antoni Garcia, Ferran Vall-Llovera, Sara Garcia-Avila, Joan Bargay, Xavier Ortin, Eva Iranzo, Francisca Guijarro, Marta Pratcorona, Josep F. Nomdedeu, Jordi Esteve, Jorge Sierra
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-024-01205-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41408-024-01205-5

Similar Items